Modulation of endothelial function by Toll like receptors

Area of Science:

• Immunology
• Vascular Biology
• Cell Biology

Background:

• Endothelial cells (ECs) regulate vascular functions including permeability, coagulation, blood pressure, and angiogenesis.
• ECs are increasingly recognized for their role in immune responses, acting as a first line of defense and tissue repair.
• Endothelial cells express pattern-recognition receptors (PRRs), notably Toll-like receptors (TLRs), which respond to pathogens and damage signals.

Purpose of the Study:

• To review the multifaceted roles of Toll-like receptors (TLRs) in modulating endothelial cell (EC) activation.
• To elucidate the significance of TLRs in immune responses to infection and the pathogenesis of vascular diseases.
• To explore the therapeutic potential of targeting TLRs in endothelial dysfunction and related pathologies.

Main Methods:

• Literature review focusing on the function of Toll-like receptors (TLRs) in endothelial cells (ECs).
• Analysis of studies investigating TLR-mediated immune responses and angiogenic processes in ECs.
• Synthesis of information on the contribution of TLRs to vascular diseases and potential therapeutic strategies.

Main Results:

• Toll-like receptors (TLRs) are key mediators of immune responses within endothelial cells (ECs).
• TLRs regulate angiogenesis, a process critical for tissue repair but also implicated in diseases.
• Dysfunctional TLR signaling in ECs contributes to inflammatory and autoimmune diseases like atherosclerosis, hypertension, and diabetes-associated cardiovascular issues.
• TLR-induced angiogenesis is involved in tumor growth, atherosclerosis, and rheumatoid arthritis.

Conclusions:

• Toll-like receptors (TLRs) are crucial in orchestrating endothelial cell (EC) activation, impacting both host defense and vascular homeostasis.
• Aberrant TLR signaling in ECs drives significant pathologies, including inflammatory vascular diseases and tumor progression.
• Targeting TLRs presents a promising therapeutic avenue for managing endothelial dysfunction and associated diseases.